[Seite 176↓]

Literaturverzeichnis

1. Pigott JD, Kouchoukos N, Oberman A : Late results of medical and surgical therapy for patients with coronary artery disease and depressed ejection fraction. Circulation. 1982, 66(Suppl.II), S. 220.

2. Hammermeister KE, Kennedy JW: Predictors of surgical mortality in patients undergoing direct myocardial revascularization. Circulation. 1979, 50, S. 112-120.

3. Zubiate P, Key JH, Mendez AM: Myocardial revascularization for patients with drastic impairment of function of the left ventricle. J Thorac Cardiovasc Surg. 1977, 73, S. 84-90.

4. The Consensus Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987, 316, S. 1449-1453.

5. Hausmann H, Warnecke H, Ennker J, Topp H, Schiessler A, Hempel B, Friedel N, Schmitt D, Hetzer R: Survival predictors in patients with a left ventricular ejection fraction of 10-30% receiving a coronary bypass:analysis of preoperative variables. Cardiovasc Surg. 1993, 5, S. 558-562.

6. Hausmann H, Ennker J, Topp H, Schüler S, Schiessler A, Hempel B, Friedel N, Hofmeister J, Hetzer R : Coronary artery bypass grafting and heart transplantation in end-stage coronary artery disease. J Card Surg. 1994, 9, S. 77-84.

7. Alderman EL, Fisher L, Litwin P, Kaiser GC, Myers WO, Maynard C, Levine F, Schloss M: Results of coronary artery surgery in patients with poor left ventricular function (Cass). Circulation. 1983, 68, S. 785-795.


[Seite 177↓]

8. Kaul TK, Agnihotri A K, Fields BL, Riggins LS, Wyatt DA, Jones CR: Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg. 1996, 111, S. 1001-1012.

9. Dreyfus G, Duboc D, Blasco A, Dubois C, Brodaty D, Chatel D, de Lentdecker PH, Bachet J, Goudot B, Piquis A, Guilmet D: Coronary surgery can be an alternative to heart transplantation in selected patients with end-stage ischemic heart disease. Eur J Cardio-thorac Surg. 1993, 7, S. 482-488.

10. Hausmann H, Warnecke H, Ennker J, Schiessler A, Hempel B, Topp H, Schüler S, Hetzer R: Koronarrevaskularisation im Endstadium der KHK in Abhängigkeit von Myokardvitalitätsprüfung. Helv chir Acta. 1991, 58, S. 495-501.

11. Bax J J, Wijns W, Cornel J H, Visser FC, Boersma E, Fioretti PM: Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease:Comparison of pooled data. J Am Coll of Cardiol. 1997, 30, S. 01451-146.

12. Hausmann H, Topp H, Siniawski H, Holz S, Hetzer R: Decision-Making in en-dstage coronary artery disease: Revascularization or heart transplantation?. Ann Thorac Surg . 1997, 64, S. 1296-1302.

13. Edmond M, Mock LD, Holmes DR, Chaitman BR, Kaiser GC, Alderman E, Killip III T: Long-term survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation. 1994, 90, S. 2645-2657.


[Seite 178↓]

14. Hildebrandt A, Reichenspurner H, Reichart B: Heart transplantation-the treatment of choice for patients with ensdstage ischaemic heart disease. Thorac Cardiovasc Surgeon. 1989, 37, S. 37-41.

15. Burch G, Giles T, Colcolough H: Ischemic cardiomyopathy. Am Heart J. 1970, 79, S.291-292.

16. Kleikamp G: Diagnostische und therapeutische Aspekte der operativen Myokardrevaskularisation der reversiblen linksventrikulären Dysfunktion. Band Habilitationsschrift. Ruhr-Universität Bochum, 1999. S. 36-69.

17. Schuster E, Bulkley B: Ischemic Cardiomyopathy: A clinicopathologic study of fourteen patients. Am Heart J. 1980, 100, S.506-512.

18. Knieriem HJ: Über den Bindegewebsgehalt des Herzmuskels des Menschen. Archiv für Kreislaufforschung. 1964, 44, S.231-258.

19. Linzbach AJ: Herzhypertrophie und kritisches Herzgewicht. Klin Wschr. 1948, 23, S.459-463.

20. Elsässer A, Schlepper M, Klövekorn WP, Cai WJ, Zimmermann R, Müller KD, Strasser R, Kostin S, Gagel C, Münkel B, Schaper W, Schaper J: Hibernating myocardium. Circulation. 1997, 96, S.2920-2931.

21. Heusch G: Hibernating myocardium. Physiological Reviews. 1998, 78, S.1055-1085.

22. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko RW, Vatner JF: Regional myocardial functional and electrophysiological alteations after brief coronary artery occlusion in conscious dogs. J Clin Invest. 1975, 56, S. 978-985.

23. Braunwald E, Kloner RA: The stunned myocardium:Prolonged postischemic ventricular dysfunction. Circulation. 1982, 66, S. 1146-1149.


[Seite 179↓]

24. Bolli R: Stunning. Circulation. 1990, 82, S. 723-738.

25. Hess ML, Kukreja RC: Myocardial stunning. J Card Surg. 1994, 9, S. 382-386.

26. Bolli R: Myocardial stunning in man. Circulation. 1992, 86, S. 1671-1691.

27. Bolli R, Zughaib, Li XY, Tang XL, Sun JZ, Triana JF, McCay PB: Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function: a pathophysiological basis for chronic myocardial "stunning". J Clin Invest. 1995, 96, S. 1066-1084.

28. Sun JZ, Kaur H, Halliwell B, Li XY, Bolli R: Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo:direct evidence for a pathogenic role of the hygroxyl radical in myocardial stunning. Circ Res. 1993, 73, S. 534-549.

29. Bolli R, Jeroudi MO, Aruoma OJ, Halliwell B, Lai EK, McCay: Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion:evidence that myocardial stunning is a manifestation of reperfusion injury. Circ Res. 1989, 65, S. 607-622.

30. Kloner RA, Bolli R, Marban E, Reinlieb B, Braunwald E: Medical and celluar implications of stunning, hibernation, and preconditioning. Circulation. 1998, 97, S. 1848-1867.

31. O`Neill PG, Charlat ML, Michael LH, Roberts R, Bolli R: Influence of neutrophil depletion on myocardial function and flow after reversible ischemia. Am J Physiol. 1989, 256, S. 341-351.


[Seite 180↓]

32. Bolli R: Role of neutrophils in myocardial stunning after brief ischemia: the end of a six-year-old-controversy (1987-1993). Cardiovasc Res. 1993, 27, S. 728-730.

33. Sun JZ, Tang XL, Park SW, Qiu Y, Turrens JF, Bolli R: Evidence for an essential rele of reactive oxgen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 1996, 97, S. 562-576.

34. Kaneko J, Beamish H, Dhalla NS: Depression of heart sarcolemmal Ca2+-pump activity by oxygen free radicals. Am J Physiol. 1989, 256, S. 368-374.

35. Kim S, Akera T: O2 free radikals:cause of ischemia reperfusion injury to cardiac Na+-K+ATPase. Am J Physiol . 1987, 252, S. 252-257.

36. Reeves JP, Bailey CA, Hale CC: Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles. J Biol Chem. 1986, 261, S. 4948-4955.

37. Gao WD, Liu Y, Marban E: Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle:implications for the mechanism of stunned myocardium. Circulation. 1996, 94, S. 2597-2604.

38. Gao W, Atar D, Liu Y, Perez MT, Murphy G, Marban E: Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res. 1997, 80, S. 393-399.

39. Kusuoka H, Koretsune Y, Chacko VP, Weisfeld ML, Marban E: Excitation-contraction coupling in postischemic myocardium: does failure of activator Ca2+ transients underlie stunning?. Circ Res. 1990, 66, S. 1268-1276.


[Seite 181↓]

40. Diamond GA, Forrester JS, De Luz PL, Wyatt HL, Swan HJC: Postextrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J. 1978, 95, S. 204-209.

41. Rahimtoola SH: Coronary bypass surgery for chronic angina-1981. Circulation. 1982, 65, S. 225-241.

42. Rahimtoola SH: The hibernating myocardium. Am Heart J. 1989, 117, S. 211-221.

43. Chen C, Chen L, Fallon JT, Ma L, Li L, Bow L, Knibbs D, McKay R, Gillam LD, Waters DD: Functional and structural alterations with 24-hour myocardial hibernation and recovery after reperfusion. A pig model of myocardial hibernation. Circulation. 1996, 94, S. 507-516.

44. Arai AE, Grauer SE, Anselone CG, Pantley GA, Bristow JD: Metabolic adaption to a gradual reduction in myocardial blood flow. Circulation. 1995, 92, S. 244-252.

45. Heusch G, Ferrari R, Hearse DJ, Ruigrok TJC, Schulz R: "Myocardial Hibernation":questions and controversies. Cardiovasc Res. 1997, 36, S. 301-309.

46. Chiariello M, Perrone-Filardi P,Ambrosio G: Hibernating and Stunned Myocardium. Cardioscience. 1993, 4, S. 63-68.

47. Bakker A, Thone F, Borgers M, Jacob W: Contact sites between the inner and outer mitochondrial membranes in stunned versus hibernating myocardium. Cardiovasc Pathol. 1995, 4, S. 195-202.


[Seite 182↓]

48. Shivalkar B, Maes A, Borgers M, Ausma J, Scheys I, Nuyts J, Mortelmans L, Flameng W: Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation. 1996, 94, S. 308-315.

49. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction:experimental observations and clinical implications. Circulation. 1990, 81, S. 1161-1172.

50. Chen C, Ma L, Dyckman w, Santos F, Lai T, Gillam L, Waters DD: Left ventricular remodeling in myocardial hibernation. Circulation. 1997, 96(suppl II), S. 46-50.

51. Bonow RO: Identification of viable myocardium. Circulation. 1996, 94, S. 2674-2680.

52. Dilsizian V, Bornow RO: Current diagnostic technique of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 87, 1993, S. 1-20.

53. Medrano R, Lowry RW, Young D, Weilbaecher DG, Michael LH, Afridi I, He ZX, Mahmarian JJ, Verani MS: Assessment of myocardial viability with 99mTc sestamibi pathological study. Circulation. 1996, 94, S. 1010-1017.

54. Qureshi U, Nagueh SF, Afridi I, Vaduganathan A, Blaustein A, Verani MS, Winters WL, Zoghbi WA, : Dobutamine echocardiography and quatitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery function. Circulation. 1997, 95, S. 626-635.


[Seite 183↓]

55. Chen C, Li L, Chen JV, Preda MH, Chen MH, Fallon ST, Weyman AE, Waters D, Gillam L: Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation. 1995, 92, S. 756-766.

56. Bax JJ, Cornel JH, Visser FC, Fioretti PM, Van Lingen A, Reijs EM, Boersma E, Teule GJJ Visser CA: Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201SPECT, thallium 201 stress reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol. 1996, 28, S. 558-564.

57. Afridi I, Qureshi U, Kopelen HA, Winters WL, Zoghbi WA: Serial changes in response of hibernating myocardium to inotropic stimulation after revascularization: a dobutamine echcardiographic study. J Am Coll Cardiol. 1997, 30, S. 1233-1240.

58. Baer FM, Voth E, Deutsch HJ, Schneider CA, Horst M, de Vivie ER, Schicha H, Erdmann E, Sechtem U: Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol. 1996, 28, S. 60-69.

59. Pagano D, Bonser GA, Townend JN, Ordoubadi F, Lorenzoni R, Camici PG: Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart. 1998, 79, S.281-288.

60. Armbrecht JJ, Schelbert HR: Myokardischämie und klinische Anwendung der Positronenemissionstomographie. Der Nuklearmediziner. 1989, 12, S. 93-107.


[Seite 184↓]

61. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke F, Bonow RO, Judd RM: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000, 343, S. 1445-1453.

62. Helfant RH, Pine R, Meister SG, Feldmann MS, Trout RG, Banka VS: Nitroglycerin to unmask reversible asynergy: correlation with postcoronary bypass ventriculography. Circulation. 1974, 50, S. 108-113.

63. Shearn DC, Brent BN: Coronary artery bypass surgery in patients with left ventricular dysfunction. Am J Med. 1986, 80, S. 405-411.

64. Freeman AP, Walsh WF, Giles RW, Choy D, Newman DC, Horton DA: Early and long term results of coronary artery bypass grafting with severely depressed left ventricular performance. Am J Cardiol. 1984, 54, S. 749-759.

65. Dreyfus G, Duboc D, Blasco a, Vigoni F, Dubois C, Brodaty D, de Lendecker P, Bachet J, Goudot B, Guilmet D : Myocardial viability assessment in ischemic cardiomyopathy:Benefits of coronary revascularization. Ann Thorac Surg. 1994, 57, S. 1402-1408.

66. Holmes DR, Detre K, Williams DO, Kent K, King S, Yeh W, Steenkiste A: Long term outcome of patients with depressed left ventricular function undergoing percutaneus transluminal coronary angioplasty. Circulation. 1993, 87, S. 21-29.

67. Tugtekin SM, Gulielmos V, Cichon R, Kappert U, Matschke K, Knaut M, Schüler S: Off-pump surgery for anterior vessels in patients with severe dysfunction of the left ventricle. Ann Thorac Surg. 2000, 70, S. 1034-1036.


[Seite 185↓]

68. Prifti E, Bonacchi M, Giunti G, Frati G, Proietti P, Laecche M, Salica A, Sani G, Brancaccio G: Does On-Pump/Beating - Heart Coronary Artery Bypass Grafting offer better Outcome in end-stage coronary artery Disease patients. J Card Surg. 2000, 15, S. 403-410.

69. Spooner TH, James CH, Rym J: A two year, three institution experience with Medtronic Octopus: systemic off-pump surgery. Ann Thorac Surg. 1999, 68, S. 1478-1481.

70. Moshkovitz Y, Sternik L, Paz Y, Gurevitch J, Feinberg MS, Smolinsky AK, Mohr R: Primary coronary artery bypass grafting without cardiopulmonary bypass in impaired left ventricular function. Ann Thorac Surg. 1997, 63, S. 44-47.

71. Trachiotis GD, Weintraub WS, Johnston TS, Jones EL, Guyton RA, Craver JM: Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg. 1998, 66, S. 16-32-1639.

72. Mickleborough LL, Maruyama H, Takagi Y, Mohamed S, Sun Z, Ebiszaki L: Results of Revascularization in patients with severe left ventricular dysfunction. circulation. 1995, 92(Suppl II), S. 73-79.

73. Beyersdorf F, Buckberg GD: Myocardial protection during surgical intervention. Texas Heart Institute Journal. 1992, 19, S.26-40.

74. Hummel M,Warnecke H, Schüler S, Hempel B, Spiegelsberger S, Hetzer R: Therapie der terminalen Herzinsuffizienz durch Herztransplantation. Klin Wochenschr. 1991, 69, S. 495-505.


[Seite 186↓]

75. Lawrie GM, Griffin JC, Wyndham CRC: Epicardial implantation of the automatic implantable defibrillator by left subcostal thoracotomy. Pace. 1984, 7, S. 1370-1374.

76. Cannom DS, Winkle RA: Implantation of the automatic implantable crdioverter defibrillator (AICD): practical aspects. Pace. 1988, 9, S. 793-809.

77. Horvath DA, Cohn LH, Cooley DA, Crew JR, Frazier OH, Griffith BP, Kadipasaoglu K, Lansing A, Mannting F, March R, Mirhoseini MR, Smith C: Transmyocardial laser revascularization: Results of a multicenter trial with myocardial laser revascularization used as sole therapy for endstage coronary artery disease. J Thoracic Cardiovasc Surg. 1997, 113, S. 645-654.

78. Krabatsch T, Petzina R, Hausmann H, Koster A, Hetzer R: Factors influenzing results and outcome after transmyocardial laser revascularization. Ann Thorac Surg. 2002, 73, S. 1888-1892.

79. Nagueh SF, Mikati I, Weilbaecher D, Reardon MJ, Al-Zaghrini GJ, Caela D, He ZX, Letsou G, Noon G, Howell JF, Espada R,Verani MS, Zoghbi WA: Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans. Circulation. 1999, 100, S. 490-496.

80. Schwarz ER, Schoendube FA, Kostin S, Schmiedtke N, Schulz G, Buell U, Messmer BJ, Morrison J, Hanrath P, Dahl J: Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol. 1998, 31, S. 1018-1026.


[Seite 187↓]

81. Hennessy T, Diamond P, Holligan B, O`Keane C, Hurley J, Codd M, McCarthy C, McCann H, Sugrue D: Correlation of myocardial histologic changes in hibernating myocardium with dobutamine stress echocardiographic findings. Am Heart J. 1998, 135, S. 952-959.

82. Dakik HA, Howell JF, Lawrie GM, Espada R, Weilbaecher DG, He ZX, Mahmarian JJ, Verani MS: Assessment of myocardial viability with 99mTc-Sestamibi Tomography before coronary bypass graft surgery. Circulation. 1997, 96, S.2892-2898.

83. Hausmann H, Topp H, Warnecke H, Ennker J, Schiessler A, Hempel B, Schüler S, Hetzer R: Wandbewegungsanalyse der linken Herzkammer bei Patienten mit koronarer Herzkrankheit und linksventrikulärer Ejektionsfraktion 10-30% vor und nach Koronarrevaskularisation. Z Herz-, Thorax-, Gefäßchir. 1992, 6, S.5-10.

84. Haas F, Augustin N, Schwaiger M, Sebening F: Die Rolle der Positronenemissionstomographie (PET) in der Diagnostik bei Patienten mit KHE und stark eingeschränkter LV-Funktion. Thorac Cardiovasc Surg. 1995, 43, S. 51-56.

85. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA: Dobutamine echcardiography in myocardial hibernating: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995, 91, S. 663-670.

86. Voller H, Nixdorff U, Flachskamp FA: Assessment of myocardial vitality with dobutamine echocardiography:current review. Z Kardiol. 2000, 89, S. 921-931.


[Seite 188↓]

87. Nixdorff U: Stress echocardiography. Z Kardiol. 2000, 89, S. 75-85.

88. Völler H, Flachskampf FA: Angewandte Echokardiographie. Band 1. Darmstadt, Steinkopff, 2000. S.35-50. ISBN 3-7985-1201-9.

89. Becher H, Tiemann K: Verbesserung der Endokarderkennung mittels modifizierter transthorakaler Echokardiographie unter Verwendung der zweiten harmonischen Schwingungen (Tissue Harmonic Imaging). Herz. 1998, 23, S.467-473.

90. Hetzer R: Experimentelle und klinische Beiträge zum Thema der chirurgischen Reperfusion des ischämischen Myokardinfarktes. Band Habilitationsschrift. Medizinische Hochschule Hannover, 1979. S. 10-68.

91. ACC/AHA Task Force Report: Guidelines for clinical use of cardiac radionuclide imaging. JACC. 1995, 25, S. 521-547.

92. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HAT, van Train KF, Berman DS: Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995, 36, S. 2138-2147.

93. Faber TL, Cooke CD, Folks RD, Vansant JP, Nichols KJ, DePuey G, Pettigrew RI, Garcia EV: Left ventricular function and perfusion from gated SPECT images:an integrated method. J Nucl Med. 1999, 40, S. 650-659.

94. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M: Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 1997, 96, S. 793-800.


[Seite 189↓]

95. Lauerma K, Niemi P, Hänninen H, Janatuinen T, Voipio-Pulkki LM, Knuuti J, Toivonen L, Mäkela T, Mäkijärvi MA, Aronen HJ: Multimodality MR Imaging Assessment of myocardial viability: Combination of first pass and late contrast enhancement to wall motion dynamics and compaison with FDG PET-Initial Experience. Radiology. 2000, 217, S. 729-736.

96. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL: Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation. 1991, 83, S. 26-37.

97. Maess AF, Borgers M, Flameng W, Nuyts JL, de Werf F, Ausma JJ, Sergeant P, Mortelmans LA: Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. J Am Coll Cardiol. 1997, 98, S. 62-68.

98. Klein C, Nekolla SG, Bengel F, Momose M, Sammer A, Haas f, Schnackenburg B, Delius W, Mudra H, Wolfram D, Schwaiger M: Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging. Circulation. 2002, 105, S. 162-167.

99. Dodge HT, Sheehan FH, Stewart DK: Estimation of ventricular volume, fractional ejected volumes, stroke volume, and quantitation of regurgitant flow. Hrsg.: Just H, Heintzen PH: Angiography. Band 1. 1. Berlin, Springer, 1986. S.99-128. ISBN 3-540-16562-2.

100. Wehr M: Praktische Elektrokardiographie und Elektrophysiologie des Herzens. Band 1. 2.Auflage.. Stuttgart/Jena, Gustav Fischer, 1994. S.23-73. ISBN 3-437-00768-8.


[Seite 190↓]

101. Jamieson SW: Aortocoronary saphenous vein bypass grafting. Hrsg.: Dudley H, Carter D: Operative Surgery. Band Cardiac Surgery. 4th edition. St.Louis/London, Mosby & Butterworths, 1986. S. 454-471. ISBN 0-407-00651.

102. Lytle BW, Loop FD: Internal mammary artery to coronary artery bypass grafting. Hrsg.: Dudley H, Carter D: Operative Surgery. Band Cardiac Surgery. 4th edition. St.Louis/London, Mosby & Butterworths, 1986. S. 471-481. ISBN 0-407-00651.

103. Larsen R: Anästhesie. Band 1. 2.Auflage. München, Urban & Schwarzenberg, 1987. S. 552-598. ISBN 3-541-11002-3.

104. Hausmann H, Photiadis J, Hetzer R: Blood flow in the internal mammary artery after the administration of papaverine during coronary artery bypass grafting. Tex Heart Inst J. 1996, 23, S.279-283.

105. Caesar R: Pathologie des Herzens. Hrsg.: Remmele W: Ischämische Herzkrankheit. Band 1. Berlin, Springer, 1998. S. 177ff.. ISBN 34-56-0007.

106. Hausmann H, Merker HJ, Hetzer R: Pressure controlled preparation of the saphenous vein with papaverine for aortocoronary venous bypass. J Card Surg. 1996, 11, S.155-162.

107. Griebenow R, Kaufmann W: Herzinsuffizienz. Hrsg.: Siegenthaler W, Kaufmann W, Hornbostel H, Waller HD: Lehrbuch der Inneren Medizin. Band 1. 2.Auflage.. Stuttgart/New York, Thieme Verlag, 1987. S. 2-11. ISBN 3-13-624302-1.

108. Campeau L: Grading of angina pectoris. Circulation. 1976, 54, S.522-531.


[Seite 191↓]

109. Hausmann H, Potapov EV, Loebe M, Koster A, Siniawski H, Lenßen K, Hetzer R: Prognosestellung nach Implantation der intraaortalen Ballonpumpe in der Herzchirurgie. Z Herz- Thorax- Gefäßchir. 1999, 13, S.249-254.

110. Hausmann H, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, Kukucka M, Sodian R, Kuppe H, Hetzer R: Prognosis after implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation. 2002, 106, I-203-206.

111. Hausmann H, Potapov EV, Koster A, Siniawski H, Kukucka M, Loebe M, Krabatsch T, Sodian R, Yeter R, Kuppe H, Hetzer R: Predictors of Survival 1 hour after implantation of an intra-aortic balloon pump in cardiac surgery. J Card Surg. 2001, 16, S.72-77.

112. Meessen H, Poche R: Pathomorphologie des Myokard. Hrsg.: Bargmann W, Doerr W: Das Herz des Menschen. Band 2. 1.Auflage. Stuttgart, Thieme, 1963. S. 704-705.

113. Elsässer A, Schaper J: Hibernating myocardium: adaption or regeneration? . Basic Res Cardiol. 1995, 90, S. 47-48.

114. Hausmann H, Siniawski H, Meyer R, Amthauer H, Gutberlet M, Felix R, Sodian R, Krabatsch T, Koster A, Kukucka M, Kuppe H, Hetzer R: Koronarbypassoperation bei hochgradig eingeschränkter Ventrikelfunktion. Dtsch med Wochenschr. 2002, 127, S. 2503-2507.

115. Kaltenbach M, Spahn F: Coronarographic nomenclature and typology of human coronary arteries. Z Kardiol. 1975, 64(3), S. 193-202.

116. Cary NC: SAS User`s Guide.Statistics and Basics. Band I. 5th Edition. New York, SAS Institute INC, 1985. S. 956-1012.


[Seite 192↓]

117. Snedecor GW, Cochran WG: Statistical Methods. Band I. 8th Edition. Des Moines, Iowa State University Press, 1989.

118. Agresti A: Categorical Data Analysis. Band I. New York, John Wiley&Sons, 1990.

119. Ausma J, van Eys GJ, Broers JL, Thone F, Flameng W, Ramaekers FC, Borgers M: Nuclear lamin expression in chronic hibernation myocardium in man. J Mol Cell Cardiol . 1996, 28, S. 1297-305.

120. Ausma J, Furst D, Thone F, Shivalkar B, Flameng w, Weber K, Ramaekers F, Borgers M: Molecular changes of titin ventricular dysfunction as a result of chronic hibernation. J Mol Cell Cardiol. 1995, 27, S. 1203-12.

121. Schwarz ER, Schaper J, vom Dahl J, Altehoefer C, Grohmann B, Schoendube F, Sheehan FH, Uebis R, Buell U, Messmer BJ, Schaper W, Hanrath P: Myocyte degeneration and cell death in hibernation human myocardium. J Am Coll Cardiol. 1996, 27, S. 1577-85.

122. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol a, Melin JA: Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted colateral-dependent myocardium. Circulation. 1993, 87, S. 1513-23.

123. Gunning MG, Chua TP, Harrington D, Knight CJ, Burmann E, Pennell DJ, Pepper J, Fox K, Underwood SR: Hibernating myocardium:clinical and functional response to revascularization. Eur J Cardiothorac Surg. 1997, 11, S. 1105-12.


[Seite 193↓]

124. Heusch G, Schulz R: The biology of myocardial hibernation. Trends Cardiovasc Med. 2000, 10, S. 108-14.

125. Borgers M, Ausma J: Structural aspects of the chronic hibernating myocardium in man. Basic Res Cardiol. 1995, 90, S. 44-6.

126. Van Meter CH, Smart FW, Ventura HO, Stapelton DD, Cassidy C, deGruiter H, Ochsner JL: High-risk surgery as an alternative to transplantation. Texas Heart Institute Journal. 1994, 21, S. 302-304.

127. Olsen PS, Kassies E, Niebuhr-Jörgensen U: Coronary artery bypass surgery in patients with severe leftventricular dysfunction. Thorac cardiovasc Surgeon. 1993, 41, S. 118-120.

128. Gummert JF, Barten MJ, Hans C, Kluge M, Doll N, Walther T, Hentschel B, Schmitt DV, Mohr FW, Diegeler A: Mediastinitis and Cardiac Surgery-an updated risk factor analysis in 10,373 consecutive adult patients. Thorac Cardiov Surg. 2002, 50, S.87-91.

12 9. Klinge R: Das Elektrokardiogramm. 5.. Stuttgart, Thieme-Verlag, 1987. S.217-270. ISBN 3-13-554005-7.

130. Leonhard H: Histologie, Zytologie und Mikroanatomie des Menschen. Taschenlehrbuch der gesamten Anatomie. Band 3. 6.. Stuttgart, Thieme-Verlag, 1981. S. 4-71. ISBN 3133715062.

131. Gheorghiade M, Bonow RO: Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998, 97, S. 282-9.

132. Schulz r, Heusch G: Hibernating myocardium. Circulation. 2000, 84, S. 587-94.


[Seite 194↓]

133. Shan K, Bick RJ, Poindexter BJ, Nagueh SF, Shimoni S, Verani MS, Keng F, Reardon MJ, Letsou GV, Howell JF, Zoghbi WA: Altered adrenergic receptor density in myocardial hibernation in humans: a possible mechanism of depressed myocardial function. Circulation. 2000, 102, S. 2599-606.

134. Bartling B, Hoffmann J, Holtz J, Schulz R, Heusch G, Darmer D: Quantification of cardioprotective gene expression in porcine short-term hibernating myocardium. J Mol Cell Cardiol. 1999, 31, S. 147-58.

135. Abbate B, Melfi R, Patti G, Baldi F, DÀmbrosio A, Manzoli a, Baldi A, Di sciasio G: Apoptosis in recent myocardial infarction. Clin Ter . 2000, 151, S. 247-51.

136. Abbate a, Biondi-Zoccai GG, Baldi A: Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol. 2002, 193, S. 145-53.

137. Gunning MG, Kaprielian RR, Pepper J, Pennell DJ, Sheppard MN, Severs NJ, Fox KM, Underwood SR: The histology of viable and hibernating myocardium in relation to imaging characteristics.. J Am Coll Cardiol. 2002, 39, S. 428-35.

138. Reinhardt D, Sigusch HH, Hensse J, Tyagi SC, Korfer R, Figulla HR: Cardiac remodelling in end stage heart failure:upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart. 2002, 88, S. 525-30.


[Seite 195↓]

139. Schimke I, Lutsch G, Schernes U, Kruse I, Dubel HP, Pregla R, Hummel M, Meyer R, Stahl J: Increased level of HSP27 but not of HSP72 in human heart allografts in relation to acute rejection. Transplantation. 2000, 70, S. 1694-7.

140. Jayakumar J, Suzuki K, Sammut IA, Smolenski RT, Khan M, Latif N, Abunasra H, Murtuza B, Amrani M, Yacoub MH: Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation. 2001, 104, S. I303-7.

141. Akcetin Z, Pregla R, Darmer D, Heynemann H, Haerting J, Bromme HJ, Holtz J: During ischemia reperfusion in rat kidneys, heat shock response is not regulated by expressional changes of heat shock factor 1. Transpl Int. 2000, 13, S. 297-302.

142. Akcetin Z, Pregla R, Darmer D, Heynemann H, Haerting J, Bromme HJ, Holtz J: Differential expression of heat shock proteins 70-1 and 70-2 mRNA after ischemia-reperfusion injury of rat kidney. Urol Res. 1999, 27, S. 306-11.

143. Fallavollita JA, Jacob S, Young RF, Canty JM jr.: Regional alterations in SR Ca(2+)-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am J Physiol. 1999, 277, S. H1418-28.

144. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olsen EN: A calcineurin-dependent transcritional pathway for cardiac hypertrophy. Cell. 1998, 93, S. 215-228.

145. Baumgarten G, Knuefermann P, Mann DL: Cytokines as emerging targets in the treatment of heartfailure . Trends Cardiovasc Med. 2000, 10, S. 216-23.


[Seite 196↓]

146. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH: Overexpression of Interleukin 1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation. 2001, 104, S. I308-13.

147. Perrone-Filardi P, Pace L, Prastaro M, Squame F, Betocchi S, Soricelli A, Piscione F, Indolfi F, Betocchi S, Soricelli A, Piscione F, Indolfi C, Crisci T, Salvatore M, Chiariello M: Assessment of myocardial viability in patients with chronic coronary artery disease. Circulation. 1996, 94, S. 2712-2719.

148. Vanoverschelde JLJ, Gerber BL, Hondt AM, De Kock M, Dion r, Wijns W, Melin JA: Preoperative selection of patients with severely impaired left venticular function for coronary revascularization. Circulation. 1995, 92, S. II-37-II-44.

149. Bullock J, Boyle J, Wang M, Ajello RR: Physiology. 1. New York, John Wiley&Sons, 1984. S. 93-137. ISBN 047109627-X.

150. Cheirif J, Meza M, Murgo JP: Dobutamine echocardiography and myocardial contrast echocardigraphy. Tex Heart Inst J. 1995, 22, S. 33-9.

151. Panza JA, Dilsizian V, Laurienzo JM, Curiel IK, Katsiyiannis PT: Relation between thallium uptake and contractile response to dobutamine: implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation. 1995, 91, S. 990-998.


[Seite 197↓]

152. Medrano R, Lowry RW, Young W, Weilbraecher DG, Lloyd M, Afridi I, He ZX, Mahmarian JJ, Verani M: Assessment of myocardial viability with Tc Sestamibi in patients undergoing cardiac transplantation. Circulation. 94, 1996, S. 1010-1017.

153. Tillisch J, Brunken R, Marshall R: Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med . 1986, 314, S.884-8.

154. Nagel E, Klein C, Schneider U, Frantz E, Ellmer a, Bocksch W, Dreysse S, Fleck E: Einfluß der Bildqualität auf die Genauigkeit der nichtinvasiven Ischämiediagnostik mit der Dobutamin-Streßmagnetresonanztomographie im Vergleich zur Dobutamin-Streßechokardiographie. Z Kardiol. 1999, 88, S. 622-30.

155. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ: Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001, 357, S. 21-28.

156. Nagueh SF, Vaduganathan P, Ali N, Blaustein A, Verani MS, Winters WL, Zoghbi WA: Identification of hibernating myocardium:Comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. JACC. 1997, 29, S. 985-93.

157. Leoncini M, Sciagra R, Bellandi F, Maioli M, Sestini S, Marcucci G, Coppola A, Frascarelli F, Mennuti A, Dabizzi RP: Low-dose dobutamin nitrate-enhanced technetium99m sestamibi gated SPECT versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy. J Nucl Cardiol. 2002, 9(4), S. 402-6.


[Seite 198↓]

158. Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H, Erdmann E: Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 1998, 31, S. 1040-8.

159. Shimoni S, Frangogiannis NG, Aggeli CJ, Shan K, Quinones MA, Espada R, Letsou GV, Lawrie GM, Winters WL, Reardon MJ, Zoghbi WA: Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernation. Circulation. 2002, 106(8), S. 950-6.

160. Frangogiannis NG, Shimoni S, Chang SM, Ren G, Dewald O, Gersch C, Shan K, Aggeli C, Reardon M, Letsou GV, Espada R, Ramchandani M, Entman ML, Zoghbi WA: Active interstitial remodeling: an important process in the hibernating human myocardium. J Am Coll Cardiol. 2002, 39(9), S. 1468-74.

161. Iskander S, Iskandrian AE: Prognostic utility of myocardial viability assessment. Am J Cardiol. 1999, 83, S. 696-702.

162. Schulz R, Rose J, Martin C, Brodde OE: Developement of short-term myocardial hibernation:its limitation by the severity of ischemia and inotropic stimulation. Circulation. 1993, 88, S.684-95.

163. Muckenthaler M, Preiss T: Mechanismen der Translationskontrolle in Eukaryonten. Hrsg.: Ganten D, Ruckpaul K: Grundlage der Molekularen Medizin. Band 1. 2. Berlin, Springer Verlag, 2003. S.152-180. ISBN 354043207-8.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
30.09.2004